Neumora Therapeutics Inc (NASDAQ: NMRA) started the day on Thursday, with a price decrease of -1.53% at $2.58, before settling in for the price of $2.62 at the close. Taking a more long-term approach, NMRA posted a 52-week range of $0.61-$14.09.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.47%. This publicly-traded company’s shares outstanding now amounts to $161.95 million, simultaneously with a float of $52.42 million. The organization now has a market capitalization sitting at $417.82 million. At the time of writing, stock’s 50-day Moving Average stood at $1.95, while the 200-day Moving Average is $1.42.
Neumora Therapeutics Inc (NMRA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Neumora Therapeutics Inc’s current insider ownership accounts for 67.63%, in contrast to 22.81% institutional ownership. According to the most recent insider trade that took place on Oct 27 ’25, this organization’s Director bought 1,915,700 shares at the rate of 2.61, making the entire transaction reach 4,999,977 in total value, affecting insider ownership by 6,046,907. Preceding that transaction, on Oct 27 ’25, Company’s 10% Owner bought 1,915,700 for 2.61, making the whole transaction’s value amount to 4,999,977. This particular insider is now the holder of 6,046,907 in total.
Neumora Therapeutics Inc (NMRA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year. Neumora Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 6.47% and is forecasted to reach -1.04 in the upcoming year.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Let’s observe the current performance indicators for Neumora Therapeutics Inc (NMRA). It’s Quick Ratio in the last reported quarter now stands at 10.54.
In the same vein, NMRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.57, a figure that is expected to reach -0.34 in the next quarter, and analysts are predicting that it will be -1.04 at the market close of one year from today.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
If we take a close look at the recent performances of Neumora Therapeutics Inc (NASDAQ: NMRA), its last 5-days Average volume was 2.53 million that shows progress from its year to date volume of 1.91 million. During the previous 9 days, stock’s Stochastic %D was recorded 47.08% While, its Average True Range was 55.28.
Raw Stochastic average of Neumora Therapeutics Inc (NMRA) in the period of the previous 100 days is set at 73.56%, which indicates a major rise in contrast to 57.59% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.31 that was higher than 0.17 volatility it exhibited in the past 100-days period.
